UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Online Course
not accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to access this content.

Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Infectious colitis is a highly prevalent condition and a major cause of morbidity worldwide. Clinical management of infectious colitis, which can be caused by various intestinal pathogens and some sexually transmitted pathogens, is a medical challenge.

This online course provides the latest information on all aspects of infectious colitis. Authors Laia Peries and Xavier Aldeguer discuss the aetiology, epidemiology, symptoms and clinical features. They describe the general diagnostic approach to infectious colitis and present a diagnostic algorithm. They also summarize the treatment options and raise awareness of complications and special situations.

Learning objectives

  • To understand how to reach a conclusive diagnosis of GORD
  • To know how to reach a conclusive diagnosis of no GORD
  • To understand how to deal with an inconclusive diagnosis

Target audience

This course is suitable for gastroenterologists in training, but it is also appropriate for physicians and surgeons in other disciplines who have an interest in infectious colitis, as well as nurses, biotechnicians and advanced-years’ medical students who have an interest in gastroenterology. 

Infectious Colitis

Infectious Colitis

Laia Peries, Xavier Aldeguer Mante

Event

Infectious Colitis

Topics

Small Intestine & Nutrition

Accreditation status

not accredited

Duration

1 hour

Published

2021
Login to access
UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to access this content.

Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Proctologic disorders are a widespread problem—their high incidence means that many different healthcare professionals (e.g. gastroenterologists, surgeons, dermatologists, nurses, young residents, etc.) will be confronted by patients complaining about a proctologic disease.

This course by European Society of Coloproctology (ESCP) experts Harald Rosen, Janindra Warusavitarne and Nuha Yassin provides the most recent state-of-the-art information on the common proctologic disorders of haemorrhoids and perianal skin conditions.

Learning objectives

  • To understand how to reach a conclusive diagnosis of GORD
  • To know how to reach a conclusive diagnosis of no GORD
  • To understand how to deal with an inconclusive diagnosis

Target audience

This course is suitable for gastroenterologists and surgeons in training, but is also appropriate for other physicians, as well as nurses, biotechnicians and medical students who have an interest in coloproctology.

Proctology — haemorrhoids and perianal skin conditions

Proctology — haemorrhoids and perianal skin conditions

Harald Rosen, Janindra Warusavitarne, Nuha Yassin

Event

Proctology — haemorrhoids and perianal skin conditions

Topics

Surgery

Accreditation status

accredited

Duration

1 hour

Published

2021
Login to access
UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to access this content.

Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Intestinal failure is the rarest organ failure, but its prevalence across Europe is increasing. Patients have complex conditions and requirements, and optimal care involves multiple specialties and disciplines. Home parenteral nutrition — the first-line treatment for chronic intestinal failure — can significantly impact patients’ lives.

This online course provides in-depth coverage of all aspects of intestinal failure and parenteral nutrition. Authors Shameer Mehta and Sarah Williams discuss the aetiology and management of short bowel syndrome, followed by the causes, classification and management of intestinal failure.

Learning objectives

  • To understand how to reach a conclusive diagnosis of GORD
  • To know how to reach a conclusive diagnosis of no GORD
  • To understand how to deal with an inconclusive diagnosis

Target audience

This course is suitable for gastroenterologists in training, colorectal surgeons, nutrition nurses, dietitians, intensivists, and other healthcare professionals looking after patients receiving parenteral nutrition.

Intestinal failure and parenteral nutrition

Intestinal failure and parenteral nutrition

Shameer Mehta, Sarah Williams

Event

Intestinal failure and parenteral nutrition

Topics

Small Intestine & Nutrition

Accreditation status

accredited

Duration

1 hour

Published

2021
Login to access
UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to access this content.

Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.

Log In Create a free account

Not sure what you can access? Learn more about account types.

About this online course

Stem cells are primitive and undifferentiated cells in human tissues (foetal and adult) with self-renewal, multipotency and longevity properties. They are responsible for cellular regeneration within the gastrointestinal tract but also play an essential role in different GI pathologies (e.g., Barrett’s oesophagus).

A gastroenterologist’s guide to stem cells, by Simon Leedham and Stuart McDonalds, covers the basic definitions of stem cells and their different locations in the gastrointestinal tract, homeostasis, the role of stem cells in intestinal regeneration, metaplasia, and tumour heterogeneity. The course includes comprehensive PPT slides, and bespoke video presentations filmed in London in December 2022. Figures, schemes, and further readings are included for consideration. The combined material has a total duration of approximately 60 minutes. The estimated time needed to complete the course, including the final assessment, is 60 minutes.

Target audience

This course is suitable for gastroenterologists in training, but is also appropriate for nurses, basic scientist in gastroenterology, medical students with interest in gastroenterology as well as other physicians (oncology, regenerative medicine, research).

Gastroenterologist's guide to stem cells

Gastroenterologist's guide to stem cells

Simon Leedham, Stuart McDonald

Event

Gastroenterologist's guide to stem cells

Accreditation status

accredited

Duration

1 hour

Published

2024
Login to access
UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to access this content.

Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.

Log In Create a free account

Not sure what you can access? Learn more about account types.

With the introduction of population-based screening programs in several countries, the proportion of patients diagnosed with early invasive colorectal cancer (T1 CRC) has been vastly increasing. There are several major challenges in clinical management of this patient group, resulting in significant practice variations among physicians.

This online course covers the most relevant aspects of clinical management of T1 CRC patients, and provides an overview of latest insights and current knowledge gaps. To facilitate the learning process, several questions on real-life patient cases have been included in which learners can bring the acquired knowledge directly into practice.

Learning objectives

  • To understand how to reach a conclusive diagnosis of GORD
  • To know how to reach a conclusive diagnosis of no GORD
  • To understand how to deal with an inconclusive diagnosis

Target audience

This course is suitable for gastroenterologists, surgeons, pathologists, nurses and any other healthcare professionals interested in, or actively involved in clinical management of T1 CRC patients. 

This course was developed by Alexandra M.J. Langers, Jurjen J. Boonstra, James C.H. Hardwick, Richard (H.) Dang et al. in receipt of an Activity Grant from UEG.

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

Alexandra Langers, Jurjen J. Boonstra, James Hardwick

Event

Management of early-invasive (T1) colorectal cancer

Topics

Digestive Oncology

Accreditation status

accredited

Duration

1 hour

Published

2020
Login to access
UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to access this content.

Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Introduction

Dysfunctional and leaky gut barrier are characteristics of cirrhosis and associated with disease progression and mortality. Utility of biomarkers, indicating the presence and extent of intestinal barrier dysfunction, remains a controversial issue in the prognosis and risk stratification of decompensated cirrhosis. Villin-1 (VIL1) is an actin-bundling protein, present in the intestinal, renal and biliary brush border. VIL1 is downregulated in response to chronic injury and diverse cellular stressors, including the microbiome, while during acute stress it is redistributed from the brush border to the basolateral membrane, which facilitates its release into the blood.

Aims & Methods

We investigated clinical significance of serum VIL1 levels in patients with cirrhosis and acute decompensation (AD).Patients (n = 86) and healthy controls (HC; n = 50) from the MICROB-PREDICT cohort were tested for serum VIL1 by ELISA. Four patient severity sub-groups were defined according to the PREDICT study (stable AD (SDC), unstable AD (UDC), pre-ACLF and ACLF [acute-on-chronic liver failure]). VIL1 immunohistochemistry (IHC) evaluation of duodenum biopsy was performed in a sub-cohort of the patients (n = 13) and controls (n = 11).

Results

Serum VIL1 levels were decreased in SDC patients (median [IQR]: 6.5 [4.9-10.4] vs 12 [8.4-14.9] ng/mL, p < 0.001) compared to controls and increased in more severe disease. This difference was confirmed in duodenum tissue by IHC. Significantly higher serum VIL1 levels were detected in pre-ACLF patients compared to those who did not develop ACLF (10.7 [7.8-22.9] vs 6.9 [5.0-10.5] ng/mL, p = 0.004), while in ACLF survivors decreased VIL1 levels were observed on day-7 compared to day-0 (9.8 [7.3-14.6] vs 12.7 [9.7-18.1] ng/mL, p = 0.010). High serum VIL1 levels (≥16.17 ng/mL) predicted 90-day mortality (AUROC:0.73, 95%CI: 0.563-0.888, p = 0.013) and in combination with high (≥ 50) CLIF-C AD score the prediction accuracy was excellent (both is high: 75%; all other together: 8% mortality, LogRank p < 0.001). High serum VIL1 level was able to predict mortality both in the presence (20% vs 62% LogRank p = 0.030) and absence (14% vs 40% LogRank p = 0.008) of renal failure.

Conclusion

Besides the six organ failures included in CLIF-SOFA, patients with cirrhosis and AD may also develop intestinal failure, as an additional organ failure. Serum VIL1 level could reliably indicate this organ failure and made the mortality risk stratification performed by CLIF-C OF score more accurate.

Disclosure

The MICROB-PREDICT project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825694

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

SERUM VILLIN-1 LEVEL – A TELL-TALE SIGN OF GUT BARRIER FAILURE IN CIRRHOTIC PATIENTS WITH ACUTE DECOMPENSATION

David Tornai 1, Boglarka Balogh 1, Aniko Csillag 1, Andras Budai 2, Andras Kiss 2, Tamas Dinya 1, Gabor Mehes 1, Lukacs Barath 1, István Tornai 1, Zsuzsanna Vitális 1, Nora Sipeki 1, Tamás Tornai 3, Peter Antal-Szalmas 1, Jonel Trebicka 4, Mária Papp 1

1 University of Debrecen, Faculty of Medicine, Debrecen, Hungary

2 Semmelweis University, Faculty of Medicine, Budapest, Hungary

3 Semmelweis University, Budapest, Hungary

4 University of Münster, Münster, Germany|||European Foundation for Study of Chronic Liver Failure, Barcelona, Spain

Conference

UEG Week Copenhagen 2023

Topics

Hepatobiliary

Submission format

Abstract

Session

Liver and biliary: Clinical aspects (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023
UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to access this content.

Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Introduction

Endoscopy abnormalities of eosinophilic esophagitis (EoE) are currently graded based on the EoE endoscopic reference score (EREFS) ranging 0 to 9. Research has shown that esophageal biopsies are often omitted in Europe in patients reporting dysphagia when the upper endoscopy (EGD) shows no abnormalities [1]. However, a proportion of patients with eosinophilic esophagitis (EoE) may have normal endoscopy (i.e., EREFS=0), making the diagnosis more difficult and increasing the risk of diagnostic delay.

Aims & Methods

We investigated predictors of a diagnosis of EoE when the EGD is unremarkable (i.e., EREFS=0). Consecutive adult patients (≥18 years) with dysphagia who had EREFS=0 at an EGD with six esophageal biopsies were prospectively enrolled. All patients underwent EGD while off any eosinophil-depleting treatment. EoE with EREFS=0 was diagnosed based on the presence of at least 15 eosinophils/high-power field in at least one of six esophageal biopsies. When all six esophageal biopsies showed <15 eosinophils/high-power field, patients were diagnosed with non-EoE dysphagia (NED). Demographics, diagnostic delay (i.e., interval time between symptoms onset and diagnosis), esophageal symptoms, and atopic comorbidities (i.e., allergic rhinitis, asthma, eczema) were collected for all patients. Pearson's Chi-squared test and Fisher's exact test were used for comparisons. Odds ratios (ORs) were calculated to quantify associations between disease states. Significance threshold was set at p<0.05.

Results

Of 133 included patients, 51 (38%) had NED, while 82 (62%) had EoE with EREFS=0. Patients with EoE were more commonly males (67% vs 35%; p<0.001) and younger (37 vs 46 years; p=0.005) compared to patients with NED. Patients with EoE were diagnosed with a significantly longer diagnostic delay than NED (28 vs 4 months; p<0.001). Heartburn, regurgitation, chest pain and dyspepsia had similar prevalence in the two groups. In contrast, patients with EoE had a significantly higher prevalence of atopic comorbidities compared to NED (83% vs 39%; p<0.001).
The presence of rhinitis, diagnostic delay longer than 12 months, any atopic comorbidity, age younger than 37 years, and male sex were associated with an increased risk of EoE with OR of 47.0, 11.6, 7.4, 3.8, and 3.7, respectively (p<0.01 for all).

Conclusion

EoE remains a possible diagnosis in patients reporting dysphagia even when endoscopy is normal. The presence of rhinitis and longer diagnostic delay, the presence of any atopic comorbidity, and younger age are associated with a diagnosis of EoE and are helpful to raise the suspicion of EoE and prompt endoscopists to collect esophageal biopsies.

CharacteristicNED (Non-EoE dysphagia) with EREFS 0
N = 51 (38%)​
EoE with EREFS 0,
N = 82 (62%)​
p-value​Odds Ratio
Sex (Male/total)18 / 51 (35%)55 / 82 (67%)<0.0013.7 (IQR, 1.6 - 8.3)
Age at diagnosis46 (40, 58)37 (28, 50)<0.013.8 (IQR, 1.4 - 10.8)
Diagnostic delay(months)4 (1, 10)28 (10, 90)<0.00111.6 (IQR, 3.8 - 40.8)
Atopy20 / 51 (39%)68 / 82 (83%)<0.0017.4 (IQR, 3.1 - 18.2)
Rhinitis3 / 51 (5.9%)62 / 82 (76%)<0.00147.6 (IQR, 13.2-264.1)

References

[1] Tourlamain, G., Garcia-Puig, R., Gutiérrez-Junquera, C., Papadopoulou, A., Roma, E., Kalach, N., Oudshoorn, J., Sokollik, C., Karolewska-Bochenek, K., Oliva, S., Strisciuglio, C., Bauraind, O., Auth, M. K., Thomson, M., Otte, S., Rok, O., Dias, J. A., Tzivinikos, C., Urbonas, V., Kostovski, A., … ESPGHAN EGID Working group (2020). Differences in Management of Eosinophilic Esophagitis in Europe: An Assessment of Current Practice. Journal of pediatric gastroenterology and nutrition, 71(1), 83–90. https://doi.org/10.1097/MPG.0000000000002672

PREDICTORS OF EOSINIPHILIC ESOPHAGITIS IN PATIENTS WITH DYSPHAGIA AND NORMAL ENDOSCOPY

PREDICTORS OF EOSINIPHILIC ESOPHAGITIS IN PATIENTS WITH DYSPHAGIA AND NORMAL ENDOSCOPY

Filippo Ovidi 1, Pierfrancesco Visaggi 1, Irene Solinas 1, Emanuele Marciano 2, Jason M. Dunn 3, Terence Wong 3, Edoardo Vincenzo Savarino 4, Nicola de Bortoli 1, Sebastian S. Zeki 3

1 Gastroenterology Unit, University of Pisa, Pisa, Italy

2 Azienda Ospedaliero Universitaria Pisana, Pisa, Italy

3 St Thomas' Hospital, London, United Kingdom

4 University of Padua, Division of Gastroenterology, Padua, Italy

Conference

UEG Week Vienna 2024

Topics

Oesophagus

Submission format

Abstract

Session

Upper functional GI disorders: From basic to clinical (Posters)

Citation

United European Gastroenterology Journal 2024; 12 (Supplement 8)

Published

2024

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.